DUBLIN--(BUSINESS WIRE)--The "Lyophilized Drugs, Reconstitution Devices and Injection Markets: Products, Markets, Therapeutics, Strategies & Forecasts" report has been added to ...

The Gujarat Food and Drug Control Administration (FDCA) has issued test license to Hyderabad-based Hetero Labs to facilitate manufacturing of lyophilized injection of remdesivir drug meant for ...

Based on approvals from Drugs Controller General of India (DCGI) and the Gujarat Food and Drug Control Administration (FDCA), Zydus Cadila has further expanded its facility in Ahmedabad to produce ...

Jubilant Life Sciences on Monday announced that its arm, Jubilant Generics, launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of ₹4,700 per vial of 100 mg ...

Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, announced that its subsidiary, Jubilant Generics Limited (“Jubilant”), has launched remdesivir for ...

GNT Pharma, a drug development venture company, announced on April 28 that it has signed a cGMP (current Good Manufacturing Practice) production contract for its investigational stroke treatment ...

On Day 2 of the distribution of lyophilized amphotericin B injections for the treatment of mucormycosis, Civil Hospital received requests for 211 injections from 30 city-based hospitals. The ...

Biologics are typically administered via injection and are thus best designed as liquid parenteral solutions. However, maintaining the stability of liquid biological products can be challenging. Many ...

In view of surging demand for antiviral drug Remdesivir, Ahmedabad-based pharma major Cadila Healthcare has decided to double its production capacity. Also known as Zydus Cadila, the company is one of ...